Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Thanks The Italian, sounds promising to me :-) Heimdal
VXR back @ 80c today with our holding valued at HK$126,400,000 eq to 29.6% of our MCap at 17.8c. Heimdal
NY based Interactive Brokers back in the market with 10 x 800,000 stacked BUY orders. Leaky ship?
Heimdal
The future is unwritten Bignose! Let's see how this pans out. Still hope. At least we have a new flash website.. lol
Tomorrow is BB-Day - Bill Beament will take the helm of VXR on July 1 - VXR now trading @ 75.5c
Heimdal
Agree Italian, positive promotion. I also noted it on Yahoo Finance.
Copper in recovery mode and VXR up 3.5% today to 72.5c, as such we have already made HK$12,900,000
in profit on our new 8c (1:7 entitlement) shares. Not bad.
A new BUY recommendation by the HK Bulls has just been issued on 575 RPG after market close.
After trading sideways for the past 3-4 months within the narrow bollinger bands it might be time
for a breakout at long last on solid FDA news.
A few days ago Young.AI was updated again. On the Apple App Store a total of 51,237 users is noted.
It will be interesting how this app will pan out, hopefully DLI will start generating some cash flow soon.
I wonder if further investments within the Longevity sector will be on the cards in 2021. DLI came out of the blue
and more deals might follow. Changing the company name for just DLI does not make much sense to me.
Next week will be very interesting. I expect a Market Update on FDA progress and potentially also some
news on the VXR 1:7 subscription (total VXR holding now valued at HK$116.5m), EU, Taiwan and DLI.
Heimdal
New name, new smart logo, new website - a new beginning. Onward and upward! Heimdal
Interactive Brokers increased their BUY orders to 14 x 700,000 on open. Interesting. Heimdal
Positive to see New York based Interactive Brokers back in the market this morning with 8 x 700,000 BUY orders.
Heimdal
603,291,547
Morning Bignose, according to the VXR Entitlement Offer Prospectus the offer documents and acceptance form will be dispatched the shareholder today June 21. However, already last Friday (June 18) it was announced to the ASX that RPG had increased its holding by 3,389,827 shares to 27,239,276 shares so it seems Jamie jumped the gun. We might see a brief market update on the VXR subscription today/this week. However as the new position is only valued at HK$1,574,776 there might not be a disclosure requirement. VXR sp mainly taking a hit on the back of the $4.8 -> $4.14/lb decline in Cu prices. Cu should recover strongly in the short-mid term. ASX dives on worst day in four months with the index down about 2% at lunch time and VXR taking a 4.5% hit. Heimdal
On May 11 RPG clearly stated that; “The Group remains on target to submit the study to the US Food and Drug Administration (“FDA”) at the end of June 2021 depending on the results of the study.” End of June... Heimdal
Hi Charlie, happy to hear you are doing very well with AMC! I am not that familiar with the stock but could well be a high risk play at this level as it might turn on a dime similar to GME. For me it would be difficult to get a proper night's rest riding these meme stocks. Sorry you did not stay the course with RPG as given the low MCap it still has the potential to be a 5-10-20 bagger if all the pieces come together. Please drop by and give us an update from time to time. Malaysia sounds like an interesting base! Cheers, Heimdal
https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0615/2021061500721.pdf
The Grantee is a consultant (the “Consultant”), namely Leverage IQ Iberica SL, of which
Mr. Lars Gehrmann is a director as well as the only and ultimate shareholder, providing
consultancy services to Deep Longevity, Inc (“DLI”), a wholly-owned subsidiary of the Group.
The grant of Option was due to services rendered pursuant to the terms of the consulting
agreement. The Consultant was engaged primarily to adapt the Group’s Young.AI App to
become an engaging tool that converts users to fee paying customers; and thereby enable
Young.AI to reach maximal exposure, by identifying potential improvements based on target
customers, conducting competitor research and providing written suggestions as to how best
to market the Young.AI App within the App itself, the App landing page and also in the App
Store. In addition, the Consultant was engaged to assess and evaluate how the Group’s aging
clocks could be partnered with insurance companies and define a roadmap and identify which
insurance companies should be approached, among other services. As disclosed in the Company’s announcement dated 2 September 2020 and circular dated 18 November 2020, upon acquiring DLI on 14 December 2020,
the Group acquired its developing explainable and user-friendly AI systems to track the rate of aging at
the molecular, cellular, tissue, organ, system, physiological and psychological levels. It is also developing
systems for the emerging field of longevity medicine enabling physicians to make better
decisions on the interventions that may slow down or reverse the aging processes. As
disclosed, DLI has developed Young.AI, a system for tracking predicted age at multiple levels
over time, with the first version of the Young.AI website and its Young.AI mobile App, an
application for App Store by Apple Inc., being launched on 29 September 2020. As further
disclosed in the aforesaid circular, like any other App providers, DLI planned to roll out future
versions as it improves its products. The Consultant was engaged as part of seeking to improve
the performance of Young.AI and such services were in line with past disclosures made and
the Group’s business scope.
The Board is pleased to announce that the Offer in respect of the Option to subscribe for
2,500,000 Shares has been duly accepted by the Grantee and that the Option should, following
the acceptance, be deemed to have been granted and to have taken effect on the Offer Date
(being 7 June 2021)."
Indeed, very frustrating Dougie. Largish seller not showing his hand in the Sell queue,
just dump 1m shares or so at the time into the Buy queue (ie. no limit sell orders). Heimdal
Extremely disappointing to see RPG trading at these low levels given the stellar performance of VXR and the imminent submission of Phase II in the US. The lack of cash flow from DLI and no clear business plan have been very disappointing, however, the DLI shares will still be in escrow for another four days. Not sure who the ?large off screen seller is, offloading a few million shares for the last few days. Hopefully we will bounce back and hold the 18c line tomorrow. MCap only 38m pounds / US$53m now! Heimdal
DLI in the news again:
https://geneticliteracyproject.org/2021/06/08/live-to-150-thats-what-some-ai-algorithms-say-is-possible-what-does-the-science-say/
Heimdal
Amazing to see RPG trading at sub 18c considering our VXR holding is now worth HK$ 125,553,789
eq to 29.2% of our MCap. Ohh well, sooner or later we will see a reevaluation. The VXR record date
for one-for-seven 8c shares is June 16 so I expect the VXR sp to climb further in the short term.
Maybe no market reaction before we exit our VXR position (later this year)?
Some big off screen sells the last few days, wonder if the DLI shares are out of escrow already
or maybe just Charlie finally closing his 8.6m position? Heimdal
Agree, the fair value seems to be is in a state of flux and under permanent review. On August 30 2016 RPG noted a "bargain purchase on the acquisition of Plethora Solutions Holdings of US$31.69 million" and as such we recorded a profit for the six months ended June 30, 2016. For 2017-18-19 we depreciated Fortacin with US$14m each year as Bignose noted, but this was changed in 2020 to US$ 25m after a new independent review, and then reduced to 19.41m on March 30, 2021.
Interim results for the six months ended 30 June 2021 will be interesting given recent developments.
Will also be interesting to follow the share price movements as we move ever closer to FDA Phase II submission in June, a major milestone! Would be good to break out of the very narrow trading range and continue the uptrend. Heimdal
No worries Dougie. Amortization is an accounting technique used to periodically lower the book value of an intangible asset, similar to depreciation. My question is how much RPG can depreciate Fortacin given recent FDA, EU and China developments. Maybe we have reached the end of the road and we will shortly see a positive profit alert? A bit more uplifting than the relentless profit warnings.. lol
Plethora Solutions was purchased for US$145m back in 2015, since then we have seen a combined amortization of US$86.4m over a 5 year period:
2017: US$ 14m
2018: US$ 14m
2019: US$ 14m
2020: US$ 25m (after a new independent review)
2021: US$ 19.41m
Current value of Fortacin is thus only US$ 58.6m and I wonder if there will be any more write downs on our main asset?
Will we see yet another profit warning in July or is the write off now completed given the Rx - OTC change in the EU, significant FDA developments, China progress etc?
Could we possibly see a positive profit alert issued in July primarily based on our VXR holding which is now valued at HK$120,000,000 or c. 28% of RPG's MCap?
A positive profit alert could be issued as early as June (example June 11, 2012) but more likely to be July.
The RPG share price is somewhat tracking the Hang Seng Index, we had a high of 31,183 on Feb 18 and now trading sideways. Other shares like Mountain Valley also peaked at that time @ C$2.19 and is now retraced back to just C$ 0.47,
I hope Charlie dingwall is doing OK after his 575 sell off on March 22 when Mountain Valley were trading at C$ 1.32.. Cathie Wood's ARK, the darling of the market last year is down 37% this year.. Not always easy to navigate in this market! I think RPG is holding up well and I am still very hopeful the sp will move north this year generated by our growing VXR holding, FDA, China and EU progress combined with potential positive DLI / further longevity developments under the new reinvigorated Endurance banner.
Heimdal.
Heimdal